| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/15/2004 | US20040138132 Membrane translocating peptide drug delivery system |
| 07/15/2004 | US20040138110 administering plasminogen activator inhibitors comprising cyclic peptides as antitumor agents; tissue-targeted therapy |
| 07/15/2004 | US20040138108 Pro-drug and use thereof as a medicament |
| 07/15/2004 | US20040138107 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same |
| 07/15/2004 | US20040138105 Modulators of polysaccharides and uses thereof |
| 07/15/2004 | US20040136907 Compounds with binding affinity for both alpha v beta 3 and somatostatin receptors; arginine, glycine, aspartic acid; improved overall affinity for tumors |
| 07/15/2004 | DE10230141B4 Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc) Method and kit for the enrichment and detection of altered prion protein (PrPSc) |
| 07/15/2004 | CA2774928A1 Binding agents which inhibit myostatin |
| 07/14/2004 | EP1436409A2 Lanthanide binding tags |
| 07/14/2004 | EP1436322A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 07/14/2004 | EP1436321A2 Synthesis of cyclosporin analogs |
| 07/14/2004 | EP1436319A2 Repetitive motifs from salivary proline rich proteins, mucin and collagen |
| 07/14/2004 | EP1436318A2 Ncam binding compounds |
| 07/14/2004 | EP1436002A1 Use of peptide vectors to improve the immune response to antigens |
| 07/14/2004 | EP1435999A1 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 07/14/2004 | EP1435989A1 Ptp1b inhibitors and ligands |
| 07/14/2004 | EP1435986A2 Igf-binding protein-derived peptide or small molecule |
| 07/14/2004 | EP1435925A2 Gap junctions and edhf |
| 07/14/2004 | EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 07/14/2004 | EP1313440A4 Dental products comprising bone growth enhancing peptide |
| 07/14/2004 | CN1513000A Anti-osteopontin antibody and use thereof |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1157482C Compond with anti fungus activity and its preparing method |
| 07/14/2004 | CN1157223C Dolastatin-15 derivatives in combination with taxanes |
| 07/13/2004 | US6762179 (2-arylamino-4-thiazole)pyrimidine compounds; useful for treating diabetes, alzheimer's disease, stroke, proliferative disorders, and asthma |
| 07/13/2004 | US6762167 Methods for treating a patient undergoing chemotherapy |
| 07/13/2004 | US6762166 Complementary peptides for the proline-glycine-proline sequence as antagonists of polymorphonuclear leukocyte chemoattractants; treating alkali-injuried eyes |
| 07/13/2004 | US6762164 Use of 3-position cyclosporin derivatives for hair growth |
| 07/13/2004 | US6761892 Heat shock protein-based vaccines and immunotherapies |
| 07/13/2004 | US6761890 Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine |
| 07/13/2004 | US6761878 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 07/13/2004 | CA2163212C Therapeutic compounds |
| 07/08/2004 | WO2004056871A2 Peptides and their use for the treatment of hiv infections |
| 07/08/2004 | WO2004056865A2 Method of modulation of interaction between receptor and ligand |
| 07/08/2004 | WO2004056309A2 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 07/08/2004 | WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 07/08/2004 | WO2004031221A9 Tumor targeting agents and uses thereof |
| 07/08/2004 | WO2003097687A3 Neuroprotective polypeptides and methods of use |
| 07/08/2004 | WO2003072061A3 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| 07/08/2004 | US20040132973 for gene therapy and vaccination; enzyme-linked immunosorbent assay (ELISA); kits; genetic engineering |
| 07/08/2004 | US20040132651 Administering modulating agent comprising histidine-alanine-valine tripeptide to treat demyelinating nervous system disorders such as multiple sclerosis; inhibits cadherin-mediated cell adhesion |
| 07/08/2004 | US20040132188 Mixture comprising modified peptides for use as facilatory tool in gene and protein transfer into cells; gene therapy; drug delivery |
| 07/08/2004 | US20040131594 Malaria therapy; using pox virus vectors; genetic engineering; antitumor agents |
| 07/08/2004 | CA2510715A1 Method of modulation of interaction between receptor and ligand |
| 07/08/2004 | CA2509423A1 Peptides and their use for the treatment of hiv infections |
| 07/08/2004 | CA2508276A1 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 07/07/2004 | EP1435360A1 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 07/07/2004 | EP1434798A2 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 07/07/2004 | EP1434792A2 Peptidyl ketones as inhibitors of dpiv |
| 07/07/2004 | EP1434791A2 Specific binding agents of human angiopoietin-2 |
| 07/07/2004 | EP1434779A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 07/07/2004 | EP1434778A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1100912B1 Method for screening of modulators of calcineurin activity |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/06/2004 | US6759520 Containing an opioid peptide moiety and a nociceptive peptide moiety for producing analgesia; used for the treatment of pain |
| 07/06/2004 | US6759510 Useful for rapid identification of biologically active compounds ;include cell-growth affecting peptides and peptides which enhance or inhibit production of cellular proteins |
| 07/06/2004 | US6759388 Surfactants that mimic the glycocalyx |
| 07/06/2004 | US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue |
| 07/06/2004 | US6759384 Factor Xa inhibitors |
| 07/01/2004 | WO2004056080A1 Endothelial cell specifically binding peptides |
| 07/01/2004 | WO2004055044A1 On-growth inhibiting compounds |
| 07/01/2004 | WO2004055043A1 Epitopic peptides of the thyroperoxidase enzyme, compositions containing same and uses thereof |
| 07/01/2004 | WO2004055042A1 Biologically active peptide conjugates |
| 07/01/2004 | WO2004018644A3 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |
| 07/01/2004 | WO2004018498A3 Minicell display and products therefrom |
| 07/01/2004 | WO2004013161A3 Peptide aggregates |
| 07/01/2004 | WO2003103608A3 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 07/01/2004 | WO2003102538A3 Combinatorial chemical library ii |
| 07/01/2004 | WO2003102015A3 Method and apparatus for detecting and monitoring peptides, and peptides identified therewith |
| 07/01/2004 | WO2003099843A3 Peptide derivatives, and their use for the synthesis of silicon-based composite materials |
| 07/01/2004 | WO2003092605A3 Protease inhibitors |
| 07/01/2004 | WO2003068942A3 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 07/01/2004 | WO2003012045A3 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 07/01/2004 | US20040127684 Heat shock protein-based vaccines and immunotherapies |
| 07/01/2004 | US20040127682 Anti-lymphocyte globulin imunotoxin fusion protein for use in prevention and treatment of graft-versus-host disease, leukemias, lymphomas and autoimmune disorders |
| 07/01/2004 | US20040127423 coadministration with and at least one therapeutic agent selected from the group consisting of an antidiabetic agent, an anti-obesity agent, a anti-hypertensive agent, an anti-atherosclerotic agent and a lipid-lowering agent |
| 07/01/2004 | US20040127419 Methods of using truncated glial cell line-derived neurotrophic factor |
| 07/01/2004 | US20040127405 Methods for treating lung infections and lung tumors and for treating and preventing lung metastases |
| 07/01/2004 | US20040126900 Water-soluble polymeric nanoparticle functionalized by at least two peptide moieties with high affinity to therapeutic and cell surface proteins |
| 07/01/2004 | US20040126810 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 07/01/2004 | US20040126410 Method for preparing zinc-oligopeptide easily absorbable by the human body |
| 07/01/2004 | CA2511665A1 Endothelial cell specifically binding peptides |
| 06/30/2004 | EP1433485A2 A uro-genital condition treatment system |
| 06/30/2004 | EP1432733A2 Gene regulatory peptides |
| 06/30/2004 | EP1432729A2 Peyers's patch and/or m-cell targeting ligands |
| 06/30/2004 | EP1432728A2 Methods and compositions for treating inflammatory disorders |
| 06/30/2004 | EP1432527A2 Biological control of nanoparticles |
| 06/30/2004 | EP1432433A2 Antagonists |
| 06/30/2004 | EP0686161B1 Novel human beta2 integrin alpha subunit |
| 06/30/2004 | CN1509294A High density lipoprotein-reactive peptides |
| 06/30/2004 | CN1508152A Somatostatin full-synthesis method |
| 06/30/2004 | CN1155617C Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 06/30/2004 | CN1155612C Endothelin antagon |
| 06/30/2004 | CN1155611C Endothelin antagon |
| 06/30/2004 | CN1155402C Compounds that inhibit interaction between signal-transducing proteins and GLGF(PDZ/DHR) domain and uses thereof |
| 06/29/2004 | US6756206 Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides |
| 06/29/2004 | US6756199 Used for the synthesis of both predefined and random sequence peptide nucleic acid oligomers |
| 06/29/2004 | CA2315230C Anti-cryptococcal peptides |
| 06/29/2004 | CA2242347C A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility |